Rapamycin can restore the negative regulatory function of transforming growth factor beta 1 in high grade lymphomas

These results suggest that high mTOR activity contributes to TGF-β resistance and lowering mTORC1 kinase activity may provide a tool in high grade B-cell lymphoma therapy by restoring the sensitivity to normally available regulators such as TGF-β1.